title: Ibandronate does not increase risk of atrial fibrillation in analysis of pivotal clinical trials.
authors.affiliation: New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM 87106, USA. lewiecki@aol.com
authors.forename: E M
authors.initials: EM
authors.lastname: Lewiecki
authors.forename: C
authors.initials: C
authors.lastname: Cooper
authors.forename: E
authors.initials: E
authors.lastname: Thompson
authors.forename: F
authors.initials: F
authors.lastname: Hartl
authors.forename: D
authors.initials: D
authors.lastname: Mehta
authors.forename: S E
authors.initials: SE
authors.lastname: Papapoulos